Focus on Asthma Care

Back to articles

Nitric oxide levels: New measure for guiding treatment of airway disease


The American Thoracic Society (ATS) has released the first-ever recommendations for use of fractionated exhaled nitric oxide (FENO) to aid in diagnosis of and clinical decisions about inflammatory airway disease. A recent clinical trial illustrates the value of FENO testing during pregnancy in women with asthma.